A. A. Yavolovskii, Yu. E. Ivanov, M. S. Fonari, L. Croitor,
L. V. Grishchuk, R. Yu. Ivanova, and G. L. Kamalov
Vol 000
177(57), 166(25). Anal. Calcd. for С13Н16N2O3: C, 55.46;
H, 5.92; N, 11.76%. Found: C, 55.44; H, 5.90; N, 11.74%.
2-(4,4-Dimethyl-2,6-dioxocyclohexylidene)-6-methyl-
1,3-dihydropyrimidin-4(1H)-one (2с) was synthesized
similar to 2a from 1a (1.42g, 0.01mmol) and 2-bromo-5,5-
dimethylcyclohexan-1,3-dione [16] (2.19g, 0.01mmol).
1H, CH pyrimid.), 2.20 (s, 3H, CH3 pyrimid.); MS m/z
(%) 174 (M+, 100), 148(7), 146(13), 145(23), 120(5), 119
(10), 92(7), 83(6), 68(24), 67(30). Anal. Calcd. for
C8H6N4O: C, 55.17; H, 3.47; N, 32.17%. Found: C,
55.23; H, 3.46; N, 32.14%.
2-(1,1-Dicyalomethylidene)-6-phenyl-1,3-dihydropyrimidin-
4(1H)-one (2g) was synthesized similar to 2e from 1b
(2.04g, 0.01 mol) and bromomalononitrile (1.45 g,
0.01 mol). White needles (C6H6), 1.1 g (46%), mp
1
White solid (ethanol), 1.42g (57%), mp 186°С; Н NMR
δ14.16 (br. s, 1H, NH), 13.84 (br. s, 1H, NH), 6.03 (s, 1H,
CH pyrimid.), 6.41 (s, 4H, CH2), 2.30 (s, 3H, CH3 pyrimid.),
1.00 (s, 6H, CH3); MS m/z (%) 248 (M+, 100), 233(5), 220
(10), 205(6), 192(9), 179(8), 164(27), 151(74). Anal. Calcd.
for С13Н16N2O3: С, 62.89; Н, 6.50; N, 11.28%. Found: С,
62.81; Н, 6.57; N, 11.21%.
1
>300°С subl.; Н NMR δ 11.35 (br. s, 2H, NH), 7.69–
7.55 (m, 5H phenyl), 6.12 (s, 1H, CH pyrimid.), 2.50 (s,
3H, CH3 pyrimid.); MS m/z (%) 236 (M+, 100), 210(20),
129(34), 117(12), 104(65), 89(7). Anal. Calcd. for
C13H8N4O: C, 66.10; H, 3.41; N, 23.72%. Found: C,
66.18; H, 3.40; N, 23.74%.
3-Amino-7-methyl-2-ethoxycarbonyl-thiazolo[3,2-
a]pyrimidin-5-one (3). To a solution of sodium ethoxide
obtained by dissolving sodium (0.23g, 0.01mol) in anhy-
drous ethanol (250mL), 6-methyl-2-thiouracil (1a) (1.42g,
0.01mol) was added with stirring. The mixture was stirred
2-(1-Cyano-1-ethoxycarbonylmethylidene)-6-methyl-1,3-
dihydropyrimidin-4(1H)-one (2d). To a solution of 6-methyl-
2-thiouracil (1a) (1.42 g, 0.01 mol) in anhydrous ethanol
(250 mL), a solution of ethyl 2-bromocyanoacetate [14]
(1.92 g, 0.01 mol) in anhydrous ethanol (50 mL) was
added slowly under stirring at 18–20°C. The resulting
mixture kept at room temperature for 30 min and refluxed
for 8 h. The reaction mixture evaporated in a rotary evap-
orator underwater pump vacuum. The residue washed
with cold water and crystallized from ethanol as white
at 18–20°C for 30min, and
a solution of ethyl
bromocyanoacetate (1.92 g, 0.01 mol) in anhydrous etha-
nol (50 mL) was added slowly. The resulting mixture
was kept at room temperature for 30 min and refluxed
for 3 h. The reaction mixture was evaporated in a rotary
evaporator under water pump vacuum. The residue was
washed with cold water and crystallized from isopropyl
alcohol as yellow needles, 1.52 g (60%), mp 134–
1
needles, 0.99 g (45%), mp 247–248°С; Н NMR δ11.97
(br. s, 1H, NH), 11.96 (br. s, 1H, NH), 5.77 (s, 1H, CH
pyrimid.), 4.18 (q, J = 7.5 Hz, 2H, CH2 ester), 2.22 s (3H,
CH3 pyrimid.), 1.24 (t, J = 7.5 Hz, 3H, CH3 ester); MS
m/z (%) 221(M+, 100), 193(21), 175(80), 149(44). Anal.
Calcd. for С13Н16N2O3: C, 54.30; H, 5.01; N, 18.99%.
Found: C, 54.28; H, 4.99; N, 18.97%.
1
135°С; Н NMR δ 8.13 (br. s, 2H, NH2), 6.11 (s, 1H,
CH pyrimidin.), 4.25 (q, J = 7.5 Hz, 2H, CH2 ester), 2.23
(s, 3H, CH3 pyrimid.), 1.27 (t, J = 7.5 Hz, 3H, CH3 ester);
ms m/z (%) 253 (M+, 100), 225(15), 207(14), 181(12),
154(15), 142(5), 121(7), 109(45). Anal. Calcd. for
C10H11N3O3S: C, 47.42; H, 4.38; N, 16.59%. Found: C,
47.38; H, 4.36; N, 16.57%.
2-(1-Cyano-1-ethoxycarbonylmethylidene)-6-phenyl-
1,3-dihydropyrimidin-4(1H)-one (2e). To a solution of
6-phenyl-2-thiouracil (1b) [17] (2.04 g, 0.01 mol) in
anhydrous ethanol (250 mL) a solution of ethyl 2-
bromocyanoacetate (1.92 g, 0.01 mol) in anhydrous
ethanol (50 mL) was gradually added under stirring at
18–20°C. The resulting mixture kept at room temperature
for 30min and refluxed for 16 h. The reaction mixture
evaporated in a rotary evaporator under water pump vac-
uum. The residue was washed with cold water and crystal-
lized from acetonitrile as white needles, 1.36 g (48%), mp.
239–240°C; 1Н NMR δ 12.97 (br. s, 1H, NH), 11.98 (br. s,
1H, NH), 7.78–7.50 (m, 5H phenyl), 6.41 (s, 1H, CH
pyrimid.), 4.22 (q, J=7.5Hz, 2H, CH2 ester), 1.26
(t, J=7.5Hz, 3H, CH3 ester); MS m/z (%) 283 (M+, 100),
255(28), 237(85), 211(85), 186(30), 181(15), 172(13),
155(6), 148(10), 141(14),129(24), 117(15), 104(52), 93(10),
89(11), 77(34). Anal. Calcd. for C15H13N3O3: C, 63.60; H,
4.63; N, 14.83%. Found: C, 63.65; H, 4.62; N, 14.84%.
2-(1,1-Dicyanomethylidene)-6-methyl-1,3-dihydro
pyrimidin-4(1H)-one (2f) was synthesized similar to 2d
from 1a (1.42 g, 0.01 mol) and bromomalononitrile [18]
(1.45 g, 0.01 mol). White solid (C6H6), 0.89 g (51%), mp
6-Methyl-2-[(2-oxopropyl)thio]pyrimidin-4(3H)-one
(4a). To a solution of sodium ethoxide obtained by dis-
solving sodium (0.23 g, 0.01 mol) in anhydrous ethanol
(250 mL), 6-methyl-2-thiouracil (1a) (1.42 g, 0.01 mol)
was added with stirring. The mixture was stirred at 18–
20°C for 30 min, and a solution of 3-chloropentane-2,4-
dione [19] (1.34 g, 0.01 mol) in anhydrous ethanol
(50 mL) was added slowly. The resulting mixture was
kept at room temperature for 30 min and refluxed for
3 h. The reaction mixture was evaporated in a rotary evap-
orator underwater pump vacuum. The residue was washed
with cold water and recrystallized from isopropyl alcohol
as white solid, 1.15 g (58%), mp 97–98°C (lit. 97°C [20]);
1Н NMR δ 12.52 (br. s, 1H, NH), 5.92 (s, 1H, CH
pyrimid.), 4.05 (s, 2H, CH2S), 2.10 (s, 3H, CH3CO),
1.91 (s, 3H, CH3 pyrimid.); MS m/z (%) 198 (M+, 17),
156(30), 155(29), 127(5), 107(18), 109(26). Anal. Calcd.
for C8H10N2O2S: C, 48.47; H, 5.08; N, 14.13%. Found:
C, 48.45; H, 5.06; N, 14.11%.
1
280°С subl.; Н NMR δ 11.80 (br. s, 2H, NH), 5.74 (s,
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet